Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Marks

Showing results (961-970 of 1,089) with videos related to

Pageof 109
Sort By:
The Journal of Urology|June 21, 2016
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SARAndrew B Rosenkrantz, Sadhna Verma, Peter Choyke, et al.
British Journal of Sports Medicine|November 29, 2015
Consensus statement on the methodology of injury and illness surveillance in FINA (aquatic sports)M Mountjoy, A Junge, J M Alonso, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2021
AP-3-dependent targeting of flippase ATP8A1 to lamellar bodies suppresses activation of YAP in alveolar epithelial type 2 cellsSeunghyi Kook, Ping Wang, Shufang Meng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trialsSumithra J Mandrekar, Donald W Northfelt, Steven E Schild, et al.
The Journal of Urology|May 6, 2014
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathologyJesse D Le, Samuel Stephenson, Michelle Brugger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
NUT midline carcinoma: an aggressive intrathoracic neoplasmSameer A Parikh, Christopher A French, Brian A Costello, et al.
Elife|September 2, 2020
Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impactMelissa A Chiasson, Nathan J Rollins, Jason J Stephany, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Genome Biology|July 2, 2023
An Atlas of Variant Effects to understand the genome at nucleotide resolutionDouglas M Fowler, David J Adams, Anna L Gloyn, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Pageof 109

Showing results (961-970 of 1,089) with videos related to

Sort By:
Pageof 109
The Journal of Urology|June 21, 2016
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SARAndrew B Rosenkrantz, Sadhna Verma, Peter Choyke, et al.
British Journal of Sports Medicine|November 29, 2015
Consensus statement on the methodology of injury and illness surveillance in FINA (aquatic sports)M Mountjoy, A Junge, J M Alonso, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2021
AP-3-dependent targeting of flippase ATP8A1 to lamellar bodies suppresses activation of YAP in alveolar epithelial type 2 cellsSeunghyi Kook, Ping Wang, Shufang Meng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Impact of pretreatment factors on adverse events: a pooled analysis of North Central Cancer Treatment Group advanced stage non-small cell lung cancer trialsSumithra J Mandrekar, Donald W Northfelt, Steven E Schild, et al.
The Journal of Urology|May 6, 2014
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathologyJesse D Le, Samuel Stephenson, Michelle Brugger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
NUT midline carcinoma: an aggressive intrathoracic neoplasmSameer A Parikh, Christopher A French, Brian A Costello, et al.
Elife|September 2, 2020
Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impactMelissa A Chiasson, Nathan J Rollins, Jason J Stephany, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2016
Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinibA S Mansfield, S J Murphy, F R Harris, et al.
Genome Biology|July 2, 2023
An Atlas of Variant Effects to understand the genome at nucleotide resolutionDouglas M Fowler, David J Adams, Anna L Gloyn, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Pageof 109